MELOXICAM
- Product NDC
- 61919-469
- 11-digit product format
- 619190469
- Labeler code
- 61919
- Product ID
- 61919-469_4d3b1449-8aaa-4caf-e063-6394a90a8a01
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- MELOXICAM
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Direct Rx
- Application
- ANDA077927
- Marketing category
- ANDA
- Marketing start
- 2014-01-01
- Substance
- MELOXICAM
- Active strength
- 15 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- MELOXICAM
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| MELOXICAM | 15 mg/1 |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | VG2QF83CGL |
| Rxcui | 152695, 311486 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| bdef11ce-16e2-4690-96a3-597bcf5cc738 | Product name | 1 | 20260130 |
| f2791553-0b76-42f4-8d49-af3eda072bfb | Product name | 1 | 20251117 |
| e3a99641-4540-4894-9108-00cab3c57b7e | Product name | 1 | 20211207 |
| 3e9b4ed6-844c-4725-9d19-cceb5c823572 | Product name | 2 | 20210903 |
| b21a682e-c765-4e26-9bb2-dbb8c7b38ef7 | Product name | 1 | 20200623 |
| a428d1db-64d7-4fc3-8d13-832b1e84b683 | Product name | 1 | 20190201 |
| 96649a58-aac8-401c-be00-450b4335f7e7 | Product name | 1 | 20161116 |
| f0761cb7-8207-3a19-2ca3-ecbb559b04e1 | Product name | 2 | 20161116 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61919-469-07 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-61d9-d83d-e063-dadaa90ab31f | MELOXICAM |
| 61919-469-15 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-61d9-d83d-e063-dadaa90ab31f | MELOXICAM |
| 61919-469-30 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-61d9-d83d-e063-dadaa90ab31f | MELOXICAM |
| 61919-469-60 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-61d9-d83d-e063-dadaa90ab31f | MELOXICAM |
| 61919-469-90 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-61d9-d83d-e063-dadaa90ab31f | MELOXICAM |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61919-469-07 | MELOXICAM | 7 in 1 BOTTLE | TABLET | 7 | 18 | |
| 61919-469-15 | MELOXICAM | 15 in 1 BOTTLE | TABLET | 15 | 18 | |
| 61919-469-30 | MELOXICAM | 30 in 1 BOTTLE | TABLET | 30 | 18 | |
| 61919-469-60 | MELOXICAM | 60 in 1 BOTTLE | TABLET | 60 | 18 | |
| 61919-469-90 | MELOXICAM | 90 in 1 BOTTLE | TABLET | 90 | 18 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 61919-469-07 | EA - Each | 61919-469 | 84dcc979-14f7-4fc1-bbf0-f7a458e5c4e3 | 1 | 2019-12-10 |
| 61919-469-10 | EA - Each | 61919-469 | fec1b4ca-48ae-465e-906f-e3913211a4cd | 1 | 2019-12-10 |
| 61919-469-15 | EA - Each | 61919-469 | d6079dc8-319d-4bd0-a3d2-53eb6087a674 | 1 | 2019-12-10 |
| 61919-469-30 | EA - Each | 61919-469 | 5fe38c9a-2f70-4f3f-af29-b0123c599d49 | 1 | 2015-10-02 |
| 61919-469-35 | EA - Each | 61919-469 | d50da42b-8e19-41c9-adc7-9c7b5630deec | 1 | 2019-12-10 |
| 61919-469-60 | EA - Each | 61919-469 | aa983cdd-eb32-49bc-8492-e5a1165311e8 | 1 | 2016-12-07 |
| 61919-469-90 | EA - Each | 61919-469 | 6e2104f7-946f-4d31-8739-5822ef8403f0 | 1 | 2014-10-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| MELOXICAM | ACTIVE INGREDIENT | VG2QF83CGL | MELOXICAM TABLET [DIRECT RX] | 1 | |
| MELOXICAM | ACTIVE MOIETY | VG2QF83CGL | MELOXICAM TABLET [DIRECT RX] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | MELOXICAM TABLET [DIRECT RX] | 1 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | MELOXICAM TABLET [DIRECT RX] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | MELOXICAM TABLET [DIRECT RX] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | MELOXICAM TABLET [DIRECT RX] | 1 | |
| POVIDONE K29/32 | INACTIVE INGREDIENT | 390RMW2PEQ | MELOXICAM TABLET [DIRECT RX] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | MELOXICAM TABLET [DIRECT RX] | 1 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | MELOXICAM TABLET [DIRECT RX] | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 152695 | meloxicam 15 MG Oral Tablet | PSN | c172a767-eb26-4995-b2a2-f3c5e87b4943 | 18 |
| 311486 | meloxicam 7.5 MG Oral Tablet | PSN | c172a767-eb26-4995-b2a2-f3c5e87b4943 | 18 |
| 152695 | meloxicam 15 MG Oral Tablet | SCD | c172a767-eb26-4995-b2a2-f3c5e87b4943 | 18 |
| 311486 | meloxicam 7.5 MG Oral Tablet | SCD | c172a767-eb26-4995-b2a2-f3c5e87b4943 | 18 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 61919-469-07 | 61919046907 | 7 TABLET in 1 BOTTLE (61919-469-07) | 7 tablet | 2014-01-01 | 0000-00-00 | No | No | Current |
| 61919-469-10 | 61919046910 | 10 TABLET in 1 BOTTLE (61919-469-10) | 10 tablet | 2014-01-01 | 0000-00-00 | No | No | Current |
| 61919-469-15 | 61919046915 | 15 TABLET in 1 BOTTLE (61919-469-15) | 15 tablet | 2014-01-01 | 0000-00-00 | No | No | Current |
| 61919-469-30 | 61919046930 | 30 TABLET in 1 BOTTLE (61919-469-30) | 30 tablet | 2014-01-01 | 0000-00-00 | No | No | Current |
| 61919-469-35 | 61919046935 | 35 TABLET in 1 BOTTLE (61919-469-35) | 35 tablet | 2014-01-01 | 0000-00-00 | No | No | Current |
| 61919-469-60 | 61919046960 | 60 TABLET in 1 BOTTLE (61919-469-60) | 60 tablet | 2014-01-01 | 0000-00-00 | No | No | Current |
| 61919-469-90 | 61919046990 | 90 TABLET in 1 BOTTLE (61919-469-90) | 90 tablet | 2014-01-01 | 0000-00-00 | No | No | Current |